Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|April 13, 2024
The Association between the rs3747406 Polymorphism in the Glucocorticoid-Induced Leucine Zipper Gene and Sepsis Survivals Depends on the SOFA ScoreStefan Rusev, Patrick Thon, Tim Rahmel, et al.
Movement Disorders Clinical Practice|October 11, 2021
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's DiseaseDavid G Standaert, Jason Aldred, Marieta Anca-Herschkovitsch, et al.
Journal of Parkinson'S Disease|June 11, 2023
Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year ResultsK Ray Chaudhuri, Norbert Kovács, Francesco E Pontieri, et al.
Neurodegenerative Disease Management|September 3, 2020
Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBEJason Aldred, Marieta Anca-Herschkovitsch, Angelo Antonini, et al.
Neurology and Therapy|January 11, 2022
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson's Disease: Real-World Evidence From G7 CountriesAngelo Antonini, Rajesh Pahwa, Per Odin, et al.
BMC Neurology|January 25, 2022
Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countriesIrene A Malaty, Pablo Martinez-Martin, K Ray Chaudhuri, et al.
Ebiomedicine|December 16, 2024
Mortality-associated plasma proteome dynamics in a prospective multicentre sepsis cohortLars Palmowski, Maike Weber, Malte Bayer, et al.
BMC Anesthesiology|January 6, 2022
The impact of the COVID-19 pandemic on non-COVID induced sepsis survivalMatthias Unterberg, Tim Rahmel, Katharina Rump, et al.
Neurology and Therapy|May 7, 2026
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim ResultsWolfgang H Jost, Filip Bergquist, Andrew Evans, et al.
Frontiers in Immunology|June 3, 2025
The protein interaction of mitochondrial transcription factors A and B2 is associated with 30-day survival in critical COVID-19Britta Westhus, Patrick Thon, Lars Palmowski, et al.
Pageof 9